lncRNA PCA3 通过负调节 miR-124-3p/ITGB1 轴抑制动脉狭窄和血管光滑肌细胞功能
1The Affiliated Taizhou Second People's Hospital of Yangzhou University, Taizhou, China.
概括
前列腺癌抗原3 (PCA3) 在动脉狭窄 (CAS) 中下调,作为生物标志物. 降低PCA3影响血管光滑肌肉细胞功能和斑块稳定性,表明治疗潜力.
科学领域:
- 心血管研究研究心血管研究
- 分子生物学分子生物学
- 生物标志物发现发现
背景情况:
- 动脉狭窄 (CAS) 往往是晚期出现的,导致严重的后果.
- 确定早期生物标志物和CAS的治疗点至关重要.
研究的目的:
- 评估长非编码RNA (lncRNA) 前列腺癌抗原3 (PCA3) 在CAS中的作用.
- 探索PCA3作为CAS的潜在治疗点.
主要方法:
- 在CAS患者和使用PCR的健康个体中比较血清PCA3水平.
- 评估PCA3对血管光滑肌细胞 (VSMC) 增殖和运动性的影响.
- 分析了稳定与不稳定的动脉斑块中的PCA3水平.
主要成果:
- 在CAS患者和不稳定的斑块中,PCA3显著下调.
- 降低PCA3水平与高胆固醇,狭窄程度和并发症等不良CAS指标相关.
- 过度表达PCA3抑制了VSMC的扩散和迁移,由miR-124-3p/ITGB1轴调节.
结论:
- PCA3作为CAS的诊断生物标志物起作用.
- 通过miR-124-3p/ITGB1通路,PCA3调节VSMC的功能.
- PCA3 间接影响状动脉斑块的稳定性,提供了一种新的治疗途径.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Mechanism of Angiogenesis
5.6K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.6K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
PI3K/mTOR/AKT Signaling Pathway
3.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.7K


